Patient's perception: shorter and more severe prodromal phase in GBA‐associated PD. (14th September 2018)

• Record Type: Journal Article
• Authors: Zimmermann, M.; Gaenslen, A.; Prahl, K.; Srulijes, K.; Hauser, A.‐K.; Schulte, C.; Csoti, I.; Berg, D.; Brockmann, K.
• Is Part Of: European journal of neurology. Volume 26:Number 4(2019)
• Page Start: 694
• Page End: 698
• Publication Date: 2018-09-14
• Subjects: GBA -- Parkinson's disease -- Prodromal phase; Neurology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/ene.13776
• Languages: English
• ISSNs: 1351-5101

Abstract

Abstract : Background: Prevalence and time of occurrence of prodromal symptoms of Parkinson's disease (PD) in relation to the onset of classical motor manifestation varies between patients. Possible modifying factors might be different genetic architectures predisposing to varying burden of manifestations. Objectives: To characterize the prodromal phase in PD patients with heterozygous mutations in the GBA gene compared to PD patients without GBA mutation. Methods: In a retrospective design, 151 participants [47 PD patients carrying a GBA mutation (PDGBA ), 52 idiopathic PD patients (PDidiopathic ), 52 healthy elderly (CON)] underwent a validated structured interview designed to assess prevalence and time of occurrence of prodromal symptoms. Results: PDGBA showed a higher prevalence of prodromal symptoms and almost simultaneous occurrence of non‐motor and early motor symptoms shortly before PD diagnosis whereas PDidiopathic reported a longer prodromal phase starting with non‐motor symptoms. Conclusion: The short and severe prodromal phase in PDGBA might call for shorter assessment intervals in yet premanifest GBA mutation carriers.